A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions
Individuals with age-related clonal hematopoiesis (CH) are at greater risk for hematologic malignancies and cardiovascular diseases. However, predictive preclinical animal models to recapitulate the spectrum of human CH are lacking. Through error-corrected sequencing of 56 human CH/myeloid malignancy genes, we identified natural CH driver mutations in aged rhesus macaques matching genes somatically mutated in human CH, with DNMT3A mutations being the most frequent. A CH model in young adult macaques was generated via autologous transplantation of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9-mediated gene-edited hematopoietic stem and progenitor cells (HSPCs), targeting the top human CH genes with loss-of-function (LOF) mutations. Long-term follow-up revealed reproducible and significant expansion of multiple HSPC clones with heterozygous TET2 LOF mutations, compared with minimal expansion of clones bearing other mutations. Although the blood counts of these CH macaques were normal, their bone marrows were hypercellular and myeloid-predominant. TET2-disrupted myeloid colony-forming units isolated from these animals showed a distinct hyperinflammatory gene expression profile compared with wild type. In addition, mature macrophages purified from the CH macaques showed elevated NLRP3 inflammasome activity and increased interleukin-1β (IL-1β) and IL-6 production. The model was used to test the impact of IL-6 blockage by tocilizumab, documenting a slowing of TET2-mutated expansion, suggesting that interruption of the IL-6 axis may remove the selective advantage of mutant HSPCs. These findings provide a model for examining the pathophysiology of CH and give insights into potential therapeutic interventions.
| Errataetall: |
CommentIn: Blood. 2022 Oct 20;140(16):1748-1750. - PMID 36264590 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:140 |
|---|---|
| Enthalten in: |
Blood - 140(2022), 16 vom: 20. Okt., Seite 1774-1789 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shin, Tae-Hoon [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 24.10.2022 Date Revised 13.03.2024 published: Print CommentIn: Blood. 2022 Oct 20;140(16):1748-1750. - PMID 36264590 Citation Status MEDLINE |
|---|
| doi: |
10.1182/blood.2021014875 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342356046 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342356046 | ||
| 003 | DE-627 | ||
| 005 | 20240313233218.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood.2021014875 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1326.xml |
| 035 | |a (DE-627)NLM342356046 | ||
| 035 | |a (NLM)35714307 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shin, Tae-Hoon |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.10.2022 | ||
| 500 | |a Date Revised 13.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Blood. 2022 Oct 20;140(16):1748-1750. - PMID 36264590 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Individuals with age-related clonal hematopoiesis (CH) are at greater risk for hematologic malignancies and cardiovascular diseases. However, predictive preclinical animal models to recapitulate the spectrum of human CH are lacking. Through error-corrected sequencing of 56 human CH/myeloid malignancy genes, we identified natural CH driver mutations in aged rhesus macaques matching genes somatically mutated in human CH, with DNMT3A mutations being the most frequent. A CH model in young adult macaques was generated via autologous transplantation of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9-mediated gene-edited hematopoietic stem and progenitor cells (HSPCs), targeting the top human CH genes with loss-of-function (LOF) mutations. Long-term follow-up revealed reproducible and significant expansion of multiple HSPC clones with heterozygous TET2 LOF mutations, compared with minimal expansion of clones bearing other mutations. Although the blood counts of these CH macaques were normal, their bone marrows were hypercellular and myeloid-predominant. TET2-disrupted myeloid colony-forming units isolated from these animals showed a distinct hyperinflammatory gene expression profile compared with wild type. In addition, mature macrophages purified from the CH macaques showed elevated NLRP3 inflammasome activity and increased interleukin-1β (IL-1β) and IL-6 production. The model was used to test the impact of IL-6 blockage by tocilizumab, documenting a slowing of TET2-mutated expansion, suggesting that interruption of the IL-6 axis may remove the selective advantage of mutant HSPCs. These findings provide a model for examining the pathophysiology of CH and give insights into potential therapeutic interventions | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 7 | |a Interleukin-1beta |2 NLM | |
| 650 | 7 | |a Inflammasomes |2 NLM | |
| 650 | 7 | |a NLR Family, Pyrin Domain-Containing 3 Protein |2 NLM | |
| 650 | 7 | |a CRISPR-Associated Protein 9 |2 NLM | |
| 650 | 7 | |a EC 3.1.- |2 NLM | |
| 650 | 7 | |a Interleukin-6 |2 NLM | |
| 650 | 7 | |a TET2 protein, human |2 NLM | |
| 650 | 7 | |a EC 1.13.11.- |2 NLM | |
| 650 | 7 | |a DNA-Binding Proteins |2 NLM | |
| 650 | 7 | |a Dioxygenases |2 NLM | |
| 650 | 7 | |a EC 1.13.11.- |2 NLM | |
| 700 | 1 | |a Zhou, Yifan |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Shirley |e verfasserin |4 aut | |
| 700 | 1 | |a Cordes, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Grice, Max Z |e verfasserin |4 aut | |
| 700 | 1 | |a Fan, Xing |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Byung-Chul |e verfasserin |4 aut | |
| 700 | 1 | |a Aljanahi, Aisha A |e verfasserin |4 aut | |
| 700 | 1 | |a Hong, So Gun |e verfasserin |4 aut | |
| 700 | 1 | |a Vaughan, Kelli L |e verfasserin |4 aut | |
| 700 | 1 | |a Mattison, Julie A |e verfasserin |4 aut | |
| 700 | 1 | |a Kohama, Steven G |e verfasserin |4 aut | |
| 700 | 1 | |a Fabre, Margarete A |e verfasserin |4 aut | |
| 700 | 1 | |a Uchida, Naoya |e verfasserin |4 aut | |
| 700 | 1 | |a Demirci, Selami |e verfasserin |4 aut | |
| 700 | 1 | |a Corat, Marcus A F |e verfasserin |4 aut | |
| 700 | 1 | |a Métais, Jean-Yves |e verfasserin |4 aut | |
| 700 | 1 | |a Calvo, Katherine R |e verfasserin |4 aut | |
| 700 | 1 | |a Buscarlet, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Natanson, Hannah |e verfasserin |4 aut | |
| 700 | 1 | |a McGraw, Kathy L |e verfasserin |4 aut | |
| 700 | 1 | |a List, Alan F |e verfasserin |4 aut | |
| 700 | 1 | |a Busque, Lambert |e verfasserin |4 aut | |
| 700 | 1 | |a Tisdale, John F |e verfasserin |4 aut | |
| 700 | 1 | |a Vassiliou, George S |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Kyung-Rok |e verfasserin |4 aut | |
| 700 | 1 | |a Dunbar, Cynthia E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d 1946 |g 140(2022), 16 vom: 20. Okt., Seite 1774-1789 |w (DE-627)NLM000014761 |x 1528-0020 |7 nnns |
| 773 | 1 | 8 | |g volume:140 |g year:2022 |g number:16 |g day:20 |g month:10 |g pages:1774-1789 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/blood.2021014875 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 140 |j 2022 |e 16 |b 20 |c 10 |h 1774-1789 | ||